NCT01978860View on ClinicalTrials.gov

A Prospective, First in Man Study to Evaluate the Safety and Performance of the NovaCross™ Micro-catheter

NACompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

November 30, 2014

Study Completion Date

December 31, 2014

Conditions
Chronic Total Occlusion of Coronary Artery
Interventions
DEVICE

NovaCross, CTO

evaluate the safety and performance of the NovaCross™ micro-catheter in respect to providing additional guidewire support that is expected to allow easier crossing of Chronic Total Occlusion (CTO) lesions in coronary arteries.

Trial Locations (1)

Unknown

Hadasa Ei Karem, Jerusalem

Sponsors
All Listed Sponsors
collaborator

Clinical Research Consultants, Inc.

INDUSTRY

lead

Chanan Schneider

INDUSTRY

NCT01978860 - A Prospective, First in Man Study to Evaluate the Safety and Performance of the NovaCross™ Micro-catheter | Biotech Hunter | Biotech Hunter